Ministry of Health, China
39
0
0
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 39 trials
100.0%
+13.5% vs industry average
13%
5 trials in Phase 3/4
7%
2 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (39)
Validation of an Artificial Intelligence System for Postoperative Management of Cataract Patients
Role: collaborator
Validation of the Utility of Ophthalmology Intelligent Diagnostic System
Role: collaborator
Non-genetic Risk Factors of Congenital Cataracts
Role: collaborator
Initial Ventilation Strategy for Adult Immunocompromised Patients With Acute Respiratory Failure
Role: collaborator
Subfoveal Choroidal Thickness After Surgery for Age-related Cataracts
Role: collaborator
A Novel Congenital Cataract Category System
Role: collaborator
An Interocular Comparative Study of Unilateral Cataract
Role: collaborator
Developmental Profile of Ocular Refraction in Patients With Congenital Cataract
Role: collaborator
Intranasal Dexmedetomidine Sedation for Ophthalmic Examinations in Children
Role: collaborator
Congenital Cataract Morphological Classifications
Role: collaborator
Validation of the Utility of Rare Disease Intelligence Platform
Role: collaborator
Patient Participation in Free Cataract Surgery
Role: collaborator
The Evolutionary Model of Mild-to-moderate Myopia in China
Role: collaborator
The Variations of Macular Thickness in Juvenile Subjects
Role: collaborator
Topical 0.1% Bromfenac Sodium and Prostaglandin E2 Inhibition in Cataract Surgery
Role: collaborator
The Effect of Cataract Surgery on Sleep Quality
Role: collaborator
Effect of the Timing of Cataract Surgery on Complications in Patients With Bilateral Congenital Cataracts
Role: collaborator
China PEACE-Prospective PCI Study
Role: collaborator
China PEACE-Prospective AMI Study
Role: collaborator
Clinical Trial of Pulmonary Cryptococcosis in China
Role: collaborator